Structure based drug design: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (2 revisions) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
Structure based drug design includes [[virtual screening]], but also more low-throughput methods such as having a medicinal chemist just look at a model and propose new compounds to make and test. | Structure based drug design includes [[virtual screening]], but also more low-throughput methods such as having a medicinal chemist just look at a model and propose new compounds to make and test. | ||
[[Category:Jargon]] | |||
Latest revision as of 20:32, 8 October 2012
Structure based drug design includes virtual screening, but also more low-throughput methods such as having a medicinal chemist just look at a model and propose new compounds to make and test.